These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9545632)
1. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Habuchi T; Luscombe M; Elder PA; Knowles MA Genomics; 1998 Mar; 48(3):277-88. PubMed ID: 9545632 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer. Habuchi T; Takahashi T; Kakinuma H; Wang L; Tsuchiya N; Satoh S; Akao T; Sato K; Ogawa O; Knowles MA; Kato T Oncogene; 2001 Jan; 20(4):531-7. PubMed ID: 11313984 [TBL] [Abstract][Full Text] [Related]
3. A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Habuchi T; Yoshida O; Knowles MA Hum Mol Genet; 1997 Jun; 6(6):913-9. PubMed ID: 9175739 [TBL] [Abstract][Full Text] [Related]
4. A sequence-ready 840-kb PAC contig spanning the candidate tumor suppressor locus DBC1 on human chromosome 9q32-q33. Nishiyama H; Hornigold N; Davies AM; Knowles MA Genomics; 1999 Aug; 59(3):335-8. PubMed ID: 10444335 [TBL] [Abstract][Full Text] [Related]
5. Homozygous deletion at the 9q32-33 candidate tumor suppressor locus in primary human bladder cancer. Nishiyama H; Takahashi T; Kakehi Y; Habuchi T; Knowles MA Genes Chromosomes Cancer; 1999 Oct; 26(2):171-5. PubMed ID: 10469456 [TBL] [Abstract][Full Text] [Related]
6. Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Nishiwaki T; Daigo Y; Kawasoe T; Nakamura Y Genes Chromosomes Cancer; 2000 Feb; 27(2):169-76. PubMed ID: 10612805 [TBL] [Abstract][Full Text] [Related]
7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761 [TBL] [Abstract][Full Text] [Related]
8. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685 [TBL] [Abstract][Full Text] [Related]
9. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
10. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286 [TBL] [Abstract][Full Text] [Related]
12. Negative regulation of G(1)/S transition by the candidate bladder tumour suppressor gene DBCCR1. Nishiyama H; Gill JH; Pitt E; Kennedy W; Knowles MA Oncogene; 2001 May; 20(23):2956-64. PubMed ID: 11420708 [TBL] [Abstract][Full Text] [Related]
13. Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma. Beetz C; Brodoehl S; Patt S; Kalff R; Deufel T Oncol Rep; 2005 Feb; 13(2):335-40. PubMed ID: 15643521 [TBL] [Abstract][Full Text] [Related]
14. Definition of a 1-Mb homozygous deletion at 9q32-q33 in a human bladder-cancer cell line. Fujiwara H; Emi M; Nagai H; Ohgaki K; Imoto I; Akimoto M; Ogawa O; Habuchi T J Hum Genet; 2001; 46(7):372-7. PubMed ID: 11450846 [TBL] [Abstract][Full Text] [Related]
15. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184 [TBL] [Abstract][Full Text] [Related]
16. Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22. MacGrogan D; Levy A; Bova GS; Isaacs WB; Bookstein R Genomics; 1996 Jul; 35(1):55-65. PubMed ID: 8661104 [TBL] [Abstract][Full Text] [Related]
17. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536 [TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of LCRG1 a novel gene localized to the tumor suppressor locus D17S800-D17S930. Li Y; Chen Z Cancer Lett; 2004 Jun; 209(1):75-85. PubMed ID: 15145523 [TBL] [Abstract][Full Text] [Related]
19. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757 [TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium. Lopez-Beltran A; Alvarez-Kindelan J; Luque RJ; Blanca A; Quintero A; Montironi R; Cheng L; Gonzalez-Campora R; Requena MJ J Pathol; 2008 Jul; 215(3):263-72. PubMed ID: 18452128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]